Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization
Tóm tắt
Từ khóa
Tài liệu tham khảo
Sadler JE., 1994, A revised classification of von Willebrand disease, Thromb Haemost, 71, 520, 10.1055/s-0038-1642471
UK Haemophilia Centre Doctors’ Organisation von Willebrand Disease Working Party, 1997, Guidelines for the diagnosis and management of von Willebrand disease, Haemophilia, 3, 4
Mannucci PM, 1992, Desmopressin: a nontransfusional treatment of hemophilia and von Willebrand disease, Haemostasis, 22, 276
De Sio L, 1985, Comparison between subcutaneous and intravenous DDAVP in mild and moderate hemophilia A, Thromb Haemost, 54, 387, 10.1055/s-0038-1657745
Casonato A, 1990, 1‐Desamino‐8‐D‐arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia, Thromb Haemost, 64, 117, 10.1055/s-0038-1647265
Casonato A, 1999, Post‐DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation, Thromb Haemost, 81, 224, 10.1055/s-0037-1614447
Fowler WE, 1989, DDAVP for type IIB von Willebrand disease, Blood, 74, 1859, 10.1182/blood.V74.5.1859.1859
British National Formulary.William Clowes Suffolk 2002;44:714.
Lindoff C, 1993, Treatment with tranexamic acid during pregnancy, and the risk of thromboembolic complications, Thromb Haemost, 70, 238, 10.1055/s-0038-1649475
Menache D, 1997, New treatments of von Willebrand disease: plasma derived von Willebrand factor concentrates, Thromb Haemost, 78, 566, 10.1055/s-0038-1657590
Scharrer I, 1994, Experience with Haemate‐P in von Willebrand's disease in adults, Haemostasis, 24, 298
Kreuz W, 1994, Haemate‐P in children with von Willebrand's disease, Haemostasis, 24, 304
Lubetsky A, 1999, Safety and efficacy of continuous infusion of a combined factor VIII‐von Willebrand factor (vWF) concentrate (Haemate‐PTM) in patients with von Willebrand disease, Thromb Haemost, 81, 229, 10.1055/s-0037-1614448
Sindet‐Pedersen S., 1991, Haemostasis in oral surgery–the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system, Dan Med Bull, 38, 427
Rodeghiero F, 1996, Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A, Thromb Haemost, 76, 692, 10.1055/s-0038-1650645
Kobrinsky N, 1997, Efficacy of Stimate (desmopressin acetate) nasal spray, 1.5 mg ml−1, for the treatment of menorrhagia in women with inherited bleeding disorders, Blood, 90, 106
Hill FG., 1982, Haematological disorders, Clin Obstet Gynaecol, 9, 75, 10.1016/S0306-3356(21)00186-2
Cattaneo M, 1989, DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor, Blood, 74, 1972, 10.1182/blood.V74.6.1972.1972
Mannucci PM., 1997, Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years, Blood, 90, 2515, 10.1182/blood.V90.7.2515
Gralnick HR, 1986, DDAVP in type IIa von Willebrand's disease, Blood, 67, 465, 10.1182/blood.V67.2.465.465
Ciavarella N, 1996, Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor, Haemostasis, 26, 150
Veyradier A, 2000, Willebrand Syndrome: from pathophysiology to management, Thromb Haemost, 4, 175, 10.1055/s-0037-1613993
AHCPR, 1992, Acute Pain Management: Operative or Medical Procedures and Trauma